Search
Last update: : 28.11.2025
EpiPROPER: Identifying epigenetic determinants of drug resistance via characterization of drug-tolerant persister cells in triple negative breast cancer Intrinsic and acquired resistance to therapy…
Last update: : 28.11.2025
Head of Division Secretary Scientists PhD Students Technicians Master Students Interns Our Division is a dynamic, international…
Last update: : 28.11.2025
Major Research Direction In the Epigenomics of hormone-driven cancers group, current projects focus on The role of 5-hydroxymethylation in cancer Profiling DNA hydroxy-/methylation and…
Last update: : 28.11.2025
PATHWAY-27 The general objective of PATHWAY-27 project addresses the exploitation of bioactive compounds as ingredients of foods that, within the common diet, could significantly benefit human…
Last update: : 28.11.2025
Endocrine therapy to block the estrogen receptor pathway in breast cancer is highly effective, but its usefulness is limited by common intrinsic and acquired resistance. In up to 20% of patients…
Last update: : 28.11.2025
Prostate cancer is the most frequent malignant tumor in males and the second most frequent cause of cancer-related death. Currently, in Germany, more than 60,000 prostate cancers are diagnosed…
Last update: : 28.11.2025
Past Projects PATHWAY-27 project Link to recent publications in breast cancer studies: Oncoimmunology 2017 Oncogene 2017 Oncotarget 2017 Clinical Epigenetics 2021 International Journal of…
Last update: : 28.11.2025
Prostate cancer (PCa) is one of the most common and heterogeneous cancers in men. The clinical course of PCa is highly variable and requires reliable prognostic markers for individualized…
Last update: : 28.11.2025
Dr. habil. Dieter Weichenhan +49 6221 42 3305 B370 Senior Scientist EDUCATION 1977-1983:Study of biology at the University of Oldenburg 1984-1989: PhD thesis (magna cum laude)Supervisor: Prof. W.…
Last update: : 27.11.2025
Dr. Maria Llamazares Prada +49 6221 42 3316 B370 Team Leader Lung Cancer Epigenomics Professional Experience 11.2020 – present DKFZ, German…